Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma

Therapeutic Advances in Hematology - United States
doi 10.1177/2040620712440589
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

SAGE Publications

Related search

Chemotherapy Adherence Is a Favorable Prognostic Factor for Elderly Patients With Multiple Myeloma Who Are Treated With a Frontline Bortezomib-Containing Regimen

Yeungnam University Journal of Medicine
2018English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

Clinical Outcomes of Bortezomib-Based Therapy in Taiwanese Patients With Multiple Myeloma: A Nationwide Population-Based Study and a Single-Institute Analysis

PLoS ONE
Multidisciplinary
2019English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma

Innovative Journal of Medical and Health Science
2019English

Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2014English

Reduced Severe Toxicities in Elderly Esophageal Cancer Patients Treated With Intensity Modulated Radiation Therapy: A Population-Based Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Primary Therapy With Single Agent Bortezomib as Induction, Maintenance and Re-Induction in Patients With High-Risk Myeloma: Results of the ECOG E2A02 Trial

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy